Reliability and Validity of the Chinese Version Appropriateness Evaluation Protocol. by Wenwei Liu, Suwei Yuan, Fengqing Wei, Jing Yang, Zhe Zhang, Changbin Zhu, Jin Ma

Get full text

Application of NGS molecular classification in the diagnosis of endometrial carcinoma: A supplement to traditional pathological diagnosis by Qunxian Rao, Jianwei Liao, Yangyang Li, Xin Zhang, Guocai Xu, Changbin Zhu, Shengya Tian, Qiuhong Chen, Hui Zhou, Bingzhong Zhang

Get full text

Association of tumor immune infiltration and prognosis with homologous recombination repair genes mutations in early triple-negative breast cancer by Zheng Wang, Anqi Li, Yujie Lu, Mengyuan Han, Miao Ruan, Chaofu Wang, Xiaotian Zhang, Changbin Zhu, Kunwei Shen, Lei Dong, Xiaosong Chen

Get full text

Novel molecular subtypes of METex14 non-small cell lung cancer with distinct biological and clinical significance by Shengnan Chen, Tao Hu, Jikai Zhao, Qian Zhu, Jin Wang, Zhan Huang, Chan Xiang, Ruiying Zhao, Changbin Zhu, Shun Lu, Yuchen Han

Get full text

COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy by Jian‐Hua Liu, Ju‐Ze Lin, Qianhui Qiu, Changbin Zhu, Weiwei Li, Qian Li, Zhan Huang, Xueer Xia, Guibin Qiao, Jiming Tang

Get full text

Genomic Profiling Comparison of Germline BRCA and Non-BRCA Carriers Reveals CCNE1 Amplification as a Risk Factor for Non-BRCA Carriers in Patients With Triple-Negative Breast Cance... by Xin Huang, Di Shao, Huanwen Wu, Changbin Zhu, Dan Guo, Yidong Zhou, Chang Chen, Yan Lin, Tao Lu, Bin Zhao, Changjun Wang, Qiang Sun

Get full text

Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma by Yuxiang Ma, Huaqiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao

Get full text

Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial by Xiao Han, Jun Guo, Lingyu Li, Yong Huang, Xue Meng, Linlin Wang, Hui Zhu, Xiangjiao Meng, Qian Shao, Xing Li, Yan Zhang, Jin Wang, Yanhua Chen, Yingjie Zhang, Yiru Chen, Changbin Zhu, Zhehai Wang

Get full text

Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trialResearch in context by Dawei Chen, Bing Zou, Butuo Li, Aiqin Gao, Wei Huang, Qian Shao, Xiangjiao Meng, Pinliang Zhang, Xiaoyong Tang, Xudong Hu, Yan Zhang, Jun Guo, Changhong Zhao, Jiajia Yuan, Qian Li, Changbin Zhu, Jinming Yu, Linlin Wang

Get full text

Tumor microenvironment biomarkers predicting pathological response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma: post-hoc analysis of a... by Qian Li, Tingting Feng, Jing Zhu, Chang Yu, Ying Yang, Qixun Chen, Dan Su, Xiaotian Zhang, Changbin Zhu, Rui Zhu, Tingting Lu, Liwei Xu, Lisha Ying, Canming Wang, Weiming Xu, Jinchao Wang, Minran Huang, Chenyang Xu, Jiaoyue Jin

Get full text

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions by Yuan Qiu, Yuan Qiu, Liping Liu, Liping Liu, Haihong Yang, Haihong Yang, Hanzhang Chen, Hanzhang Chen, Qiuhua Deng, Qiuhua Deng, Dakai Xiao, Dakai Xiao, Yongping Lin, Yongping Lin, Changbin Zhu, Weiwei Li, Di Shao, Wenxi Jiang, Kui Wu, Jianxing He, Jianxing He

Get full text

Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phas... by Wei Huang, Yan Zhang, Hui Zhu, Xiao Han, Yingjie Zhang, Jun Guo, Linlin Wang, Ying Hua, Xiangjiao Meng, Zhehai Wang, Xiaoyong Tang, Dongyuan Zhu, Xiqin Zhang, Zhongtang Wang, Shuanghu Yuan, Pinliang Zhang, Heyi Gong, Yulan Sun, Zengjun Liu, Xiaomeng Dong, Fei Gai, Zhan Huang, Changbin Zhu

Get full text